Your Doctol get income only if you are sick. Guess what they will not tell
you:

http://www.mercola.com/2005/mar/9/prostate_cancer.htm

More than any other cancer and representing about one-third of all cancers
diagnosed among men, prostate cancer is estimated to occur in more than
220,000 men in 2005.
From the minute a patient is diagnosed with this cancer, they are faced with
a number of difficult treatment decisions; for some men, the disease will
continue to progress, resistant to all treatment forms. Governments do not
research prostate cancer but only breast cancer as that brings more votes.

The question of whether PSA screening does in fact reduce mortality from
prostate cancer must be answered by large-scale clinical trials, which are
currently underway. PSA-related findings thus far include:

 a.. Relative five-year survival rates for prostate cancer patients were 99
percent

 b.. 10-year survival rates were 95 percent

 c.. Excess mortality compared with the general population was as low as 1
percent and 5 percent within five and 10 years following diagnosis

Cut the Risk of Prostate Cancer with Sunshine?

One specific treatment for prostate cancer brought to the "research
forefront" is sunshine. According to a study, men with higher levels of
vitamin D (typically obtained through sunshine exposure) in their blood were
half as likely to develop aggressive forms of prostate cancer than those
with lower amounts. Experiments also suggested vitamin D inhibits cell
growth.

Yet despite sunshine's apparent health benefits, doctors are not entirely
comfortable with prescribing the "sunshine vitamin," though many see little
harm in getting the 15 minutes of exposure time a day the body needs to make
enough of this vital nutrient. (It is recommended people get a daily vitamin
D amount of 400 international units.) Doctors warn, however, that there must
be a "happy medium" to receiving vitamin D: Too little won't do any good,
while an overload can cause critical health problems such as skin cancer.

Journal of Clinical Oncology January 20, 2005; Vol. 23, 407-409

USA Today February 17, 200

http://www.medicinenet.com/script/main/art.asp?articlekey=23592

Cancer Prevention and Red Wine
Red wine is a rich source of biologically active phytochemicals, chemicals
found in plants. Particular compounds called polyphenols found in red wine,
such as catechins and resveratrol, are thought to have anti oxidant or anti
cancer properties.

What are polyphenols and how do they prevent cancer?

Polyphenols are antioxidant compounds found in the skin and seeds of grapes.
When wine is made from these grapes, the alcohol produced by the
fermentation process dissolves the polyphenols contained in the skin and
seeds. Red wine contains more polyphenols than white wine because the making
of white wine requires the removal of the skins after the grapes are
crushed. The phenols in red wine include catechin, gallic acid, and
epicatechin.

Polyphenols have been found to have antioxidant properties. Antioxidants are
substances that protect cells from oxidative damage caused by molecules
called free radicals. These chemicals can damage important parts of cells,
including proteins, membranes, and DNA. Cellular damage caused by free
radicals has been implicated in the development of cancer. Research on the
antioxidants found in red wine has shown that they may help inhibit the
development of certain cancers.

What is resveratrol and how does it prevent cancer?

Resveratrol is a type of polyphenol called a phytoalexin, a class of
compounds produced as part of a plant's defense system against disease. It
is produced in the plant in response to an invading fungus, stress, injury,
infection, or ultraviolet irradiation. Red wine contains high levels of
resveratrol, as do grapes, raspberries, peanuts, and other plants.

Resveratrol has been shown to reduce tumor incidence in animals by affecting
one or more stages of cancer development. It has been shown to inhibit
growth of many types of cancer cells in culture. Evidence also exists that
it can reduce inflammation. It also reduces activation of NF kappa B, a
protein produced by the body's immune system when it is under attack. This
protein affects cancer cell growth and metastasis. Resveratrol is also an
antioxidant.

What have red wine studies found?

The cell and animal studies of red wine have examined effects in several
cancers including leukemia, skin , breast, and prostate cancers . Scientists
are studying resveratrol to learn more about its cancer preventive
activities. Recent evidence from animal studies suggests this
anti-inflammatory compound may be an effective chemopreventive agent in
three stages of the cancer process: initiation, promotion, and progression.

However, studies of the association between red wine consumption and cancer
in humans are in their initial stages. Although consumption of large amounts
of alcoholic beverages may increase the risk of some cancers, there is
growing evidence that the health benefits of red wine are related to its
nonalcoholic components.